Clinical Trial Update: Seroquel XR in the Long Term Treatment of Schizophrenia

View source ↗

Summary

A completed clinical trial evaluated quetiapine extended-release (Seroquel XR) for long-term treatment of schizophrenia to reduce relapse risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Relapse in Schizophrenia | Status: COMPLETED